Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Cases of high consequence infectious diseases identified in the UK, 1962–2023

Atkinson B. et al, (2025), Journal of Medical Microbiology, 74

Inferring transmission risk of respiratory viral infection from the viral load kinetics of SARS-CoV-2, England, 2020 to 2021 and influenza A virus, Hong Kong, 2008 to 2012.

Jonnerby J. et al, (2025), Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 30

Clinical characterisation and outcomes of human clade IIb mpox virus disease - a European multicentre observational cohort study (MOSAIC).

Pesonel E. et al, (2025), Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Ebola disease: bridging scientific discoveries and clinical application.

Rojek A. et al, (2024), The Lancet. Infectious diseases

Embedding treatment in stronger care systems

Rojek A. et al, (2024), The Lancet Infectious Diseases

The worsening mpox outbreak in Africa: a call to action.

Kuppalli K. et al, (2024), The Lancet. Infectious diseases

Mpox: The alarm went off. Have we gone back to sleep?

Olliaro P. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011871 - e0011871

Variability in clinical assessment of clade IIb mpox lesions

Jones B. et al, (2023), International Journal of Infectious Diseases, 137, 60 - 62

Mpox virus DNA contamination can still be detected by qPCR analysis after autoclaving.

Spencer A. et al, (2023), The Journal of hospital infection

Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19

Kartsonaki C. et al, (2023), International Journal of Epidemiology, 52, 355 - 376

Randomised controlled trials for mpox in endemic countries.

Rojek A. et al, (2023), The Lancet. Infectious diseases, 23

High consequence infectious diseases in Europe - the need for an expert clinical support service

Brantsæter A. et al, (2023), Population Medicine, 5, 116 - 116

MOSAIC: A cohort study of human mpox virus disease.

Pesonel E. et al, (2023), Wellcome open research, 8

Tecovirimat for Monkeypox in Central African Republic under Expanded Access.

Mbrenga F. et al, (2022), The New England journal of medicine, 387, 2294 - 2295

Monkeypox as an emerging infectious disease: the ophthalmic implications

Milligan AL. et al, (2022), British Journal of Ophthalmology

Fitting to the UK COVID-19 outbreak, short-term forecasts and estimating the reproductive number

Keeling MJ. et al, (2022), Statistical Methods in Medical Research, 31, 1716 - 1737

Monkeypox: how will we know if the treatments work?

Rojek A. et al, (2022), The Lancet. Infectious diseases, 22, 1269 - 1270

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Adler H. et al, (2022), The Lancet Infectious Diseases, 22, 1153 - 1162

Monkeypox virus contamination in an office-based workplace environment.

Atkinson B. et al, (2022), The Journal of hospital infection

Broadening symptom criteria improves early case identification in SARS-CoV-2 contacts.

Houston H. et al, (2022), The European respiratory journal, 60

Load More